Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / virus - Page 26

virus

National Science Foundation awarded rapid response grants to support coronavirus (COVID-19) research
COVID-19 | Life Science History

National Science Foundation awarded rapid response grants to support coronavirus (COVID-19) research

On Apr. 21, 2020, the National Science Foundation (NSF) issued a letter to researchers inviting proposals for rapid…

Read More National Science Foundation awarded rapid response grants to support coronavirus (COVID-19) researchContinue

VA researchers announced study of COVID-19 in aging Veterans with dementia
Biotechnology | COVID-19 | Disease

VA researchers announced study of COVID-19 in aging Veterans with dementia

On Apr. 21, 2020, researchers at the U.S. Department of Veterans Affairs’ (VA) Providence VA Medical Center began…

Read More VA researchers announced study of COVID-19 in aging Veterans with dementiaContinue

ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trials
COVID-19 | FDA | Pharmaceutical | Therapeutics

ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trials

On Apr. 21, 2020, BioSig Technologies announced that subsidiary ViralClear Pharmaceuticals, had submitted an application for Vicromax(tm) (merimepodib,…

Read More ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trialsContinue

Quest Diagnostics began performing COVID-19 antibody testing
COVID-19 | Life Science History

Quest Diagnostics began performing COVID-19 antibody testing

On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…

Read More Quest Diagnostics began performing COVID-19 antibody testingContinue

New virus detection process under development at Rutgers-Camden
COVID-19 | Life Science History

New virus detection process under development at Rutgers-Camden

On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…

Read More New virus detection process under development at Rutgers-CamdenContinue

Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients
COVID-19 | Life Science History

Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients

On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…

Read More Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patientsContinue

Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needs
COVID-19 | Diagnostics | Medical Device | Medicine | Therapeutics

Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needs

On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…

Read More Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needsContinue

Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus
Biotechnology | COVID-19 | Therapeutics

Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus

On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…

Read More Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virusContinue

RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19
Biotechnology | NIH | Therapeutics

RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19

On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…

Read More RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19Continue

USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County
Biotechnology | COVID-19 | Diagnostics

USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County

On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…

Read More USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles CountyContinue

Oxford University project assessed Coronavirus infection rates in children and teenagers across UK
Biotechnology | COVID-19 | Diagnostics

Oxford University project assessed Coronavirus infection rates in children and teenagers across UK

On Apr. 20, 2020, a multi-site project, called ‘What’s the STORY?’ received funding from UK Research and Innovation…

Read More Oxford University project assessed Coronavirus infection rates in children and teenagers across UKContinue

Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
COVID-19 | FDA | Life Science History

Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19

On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…

Read More Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19Continue

Rice University  COVID-19 research fund awarded first grants
Biotechnology | COVID-19 | Diagnostics | Therapeutics

Rice University COVID-19 research fund awarded first grants

On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…

Read More Rice University COVID-19 research fund awarded first grantsContinue

Antiviral remdesivir prevented disease progression in monkeys with COVID-19
COVID-19 | NIH | Therapeutics

Antiviral remdesivir prevented disease progression in monkeys with COVID-19

On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…

Read More Antiviral remdesivir prevented disease progression in monkeys with COVID-19Continue

Five Oxford University COVID-19 projects received UK Research and Innovation funding
COVID-19 | Non-Profit Research | Therapeutics | Vaccine

Five Oxford University COVID-19 projects received UK Research and Innovation funding

On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…

Read More Five Oxford University COVID-19 projects received UK Research and Innovation fundingContinue

Roche developed new serology test to detect COVID-19 antibodies
Biotechnology | COVID-19 | Diagnostics

Roche developed new serology test to detect COVID-19 antibodies

On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…

Read More Roche developed new serology test to detect COVID-19 antibodiesContinue

Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people
COVID-19 | Non-Profit Research | Vaccine

Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people

On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…

Read More Kaiser Permanente Washington announced Coronavirus vaccine trial to include older peopleContinue

FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.
COVID-19 | FDA | Medical Device | Therapeutics

FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.

On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…

Read More FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.Continue

Emory University Began enrolling older adults in COVID-19 vaccine clinical trial
COVID-19 | Life Science History | Vaccine

Emory University Began enrolling older adults in COVID-19 vaccine clinical trial

On Apr. 17, 2020, Emory University announced it had begun enrolling adults over age 55 in the clinical…

Read More Emory University Began enrolling older adults in COVID-19 vaccine clinical trialContinue

Celdara Medical entered into a CRADA with USAMRIID and the Geneva Foundation
Biotechnology | Disease | Influenza | Therapeutics | Vaccine

Celdara Medical entered into a CRADA with USAMRIID and the Geneva Foundation

On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…

Read More Celdara Medical entered into a CRADA with USAMRIID and the Geneva FoundationContinue

Slower clearance of Coronavirus infection may explain why men fare worse than women
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Therapeutics

Slower clearance of Coronavirus infection may explain why men fare worse than women

On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…

Read More Slower clearance of Coronavirus infection may explain why men fare worse than womenContinue

University of Washington blood test detected past infections with new coronavirus
Biotechnology | Diagnostics | Non-Profit Research | Therapeutics

University of Washington blood test detected past infections with new coronavirus

On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…

Read More University of Washington blood test detected past infections with new coronavirusContinue

Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine
COVID-19 | FDA | Life Science History

Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccine

On Apr. 16, 2020, Dynavax and Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced a…

Read More Dynavax and Sinovac announced collaboration to develop a Coronavirus (COVID-19) vaccineContinue

Scripps Research expanded international effort to rapidly repurpose existing drugs against COVID-19
Life Science History

Scripps Research expanded international effort to rapidly repurpose existing drugs against COVID-19

On Apr. 16, 2020, Scripps Research announced that researchers at Calibr, Scripp’s drug development division, had established an…

Read More Scripps Research expanded international effort to rapidly repurpose existing drugs against COVID-19Continue

Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus
Biotechnology | Infectious Disease | Vaccine

Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel Coronavirus

On Apr. 16, 2020, Moderna announced an agreement for a commitment of up to $483 million from the…

Read More Moderna announced BARDA award for up to $483 million to accelerate development of mRNA vaccine (mRNA-1273) against novel CoronavirusContinue

FDA accepted for Priority Review Biologics License Application for REGN-EB3 to treat Ebola
FDA | Life Science History

FDA accepted for Priority Review Biologics License Application for REGN-EB3 to treat Ebola

On Apr. 16, 2020, Regeneron announced the FDA has accepted for Priority Review a new Biologics License Application…

Read More FDA accepted for Priority Review Biologics License Application for REGN-EB3 to treat EbolaContinue

U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine

U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19

On Apr. 15, 2020, scientists at the University of Alberta have shown that the drug remdesivir is highly…

Read More U of A virology lab finds drug originally meant for Ebola effective against key enzyme of coronavirus that causes COVID-19Continue

Abbott launched third COVID-19 test, a laboratory-based antibody blood test
COVID-19 | Life Science History | Vaccine

Abbott launched third COVID-19 test, a laboratory-based antibody blood test

On Apr. 15, 2020, Abbott announced the launch of its third COVID-19 test, a lab-based serology blood test…

Read More Abbott launched third COVID-19 test, a laboratory-based antibody blood testContinue

NIH study validated decontamination methods for re-use of N95 respirators
COVID-19 | Life Science History

NIH study validated decontamination methods for re-use of N95 respirators

On Apr. 15, 2020, N95 respirators can be decontaminated effectively and maintain functional integrity for up to three…

Read More NIH study validated decontamination methods for re-use of N95 respiratorsContinue

Queensland University announced new mask material made from sugar cane removed virus-size nanoparticles
Life Science History | Nanotechnology

Queensland University announced new mask material made from sugar cane removed virus-size nanoparticles

On Apr. 15, 2020, Queensland University of Technology (QUT) reported it had developed and tested a highly breathable…

Read More Queensland University announced new mask material made from sugar cane removed virus-size nanoparticlesContinue

Page navigation

Previous PagePrevious 1 … 24 25 26 27 28 … 40 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search